Table 3.
Methyltransferase inhibition data and molecular docking scores for 13 – 18 with varying western arene (R1) and azetidine subsituent (R2).
| ||||||
|---|---|---|---|---|---|---|
| Compound | R1 | R2 | NpmA Glide XP (kcal/mol) | %Inhibition (1 mM, NpmA) | RmtB Glide XP (kcal/mol) | %Inhibition (1 mM, RmtB) |
| 13 | CN | Me | −5.0 | 16 ± 6 | −6.4 | NI |
| 14 | C(O)NH2 | Me | −4.9 | 16 ± 4 | −5.5 | NI |
| 15 | C(O)NH2 | H | −8.7 | 46 ± 5 | −5.7 | 52 ± 10 |
| 16 | C(O)NH2 | Boc | −8.2 | 32 ± 13 | −7.8 | NI |
| 17 | CN | H | −5.5 | NI | −6.1 | NI |
| 18 | C(O)Me | H | −9.7 | 7 ± 1 | −6.0 | NI |
NI = no inhibition.